Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Modest

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cancer Research|May 1, 1975
N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycinM Israel, E J Modest, E Frei
Anticancer Research|July 1, 1995
Cell kill and cytostasis by ET-18-OCH3 and heatK Fujiwara, E J Modest, C A Wallen
Biochimica Et Biophysica Acta|November 3, 1988
Effects of antineoplastic ether lipids on model and biological membranesA Noseda, P L Godwin, E J Modest
Journal of Medicinal Chemistry|September 1, 1975
Methotrexate analogs. 6. Replacement of glutamic acid by various amino acid esters and aminesM Chaykovsky, B L Brown, E J Modest
Lipids|April 1, 1994
Superoxide production by macrophages stimulated in vivo with synthetic ether lipidsB M Schreiber, M D Layne, E J Modest
Journal of Lipid Research|September 1, 1995
Animal cell mutants unable to take up biologically active glycerophospholipidsR A Zoeller, M D Layne, E J Modest
Cancer Research|June 1, 1976
Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerateA Krishan, M Israel, E J Modest, et al.
Biochemical Pharmacology|June 22, 1993
Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cellsE E Kelley, E J Modest, C P Burns
Lipids|March 1, 1993
The effect of culture medium composition on ether lipid cytotoxic activityL Diomede, B Piovani, E J Modest, et al.
Lipids|November 1, 1987
Neoplastic cell inhibition with new ether lipid analogsA Noseda, M E Berens, C Piantadosi, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cancer Research|May 1, 1975
N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycinM Israel, E J Modest, E Frei
Anticancer Research|July 1, 1995
Cell kill and cytostasis by ET-18-OCH3 and heatK Fujiwara, E J Modest, C A Wallen
Biochimica Et Biophysica Acta|November 3, 1988
Effects of antineoplastic ether lipids on model and biological membranesA Noseda, P L Godwin, E J Modest
Journal of Medicinal Chemistry|September 1, 1975
Methotrexate analogs. 6. Replacement of glutamic acid by various amino acid esters and aminesM Chaykovsky, B L Brown, E J Modest
Lipids|April 1, 1994
Superoxide production by macrophages stimulated in vivo with synthetic ether lipidsB M Schreiber, M D Layne, E J Modest
Journal of Lipid Research|September 1, 1995
Animal cell mutants unable to take up biologically active glycerophospholipidsR A Zoeller, M D Layne, E J Modest
Cancer Research|June 1, 1976
Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerateA Krishan, M Israel, E J Modest, et al.
Biochemical Pharmacology|June 22, 1993
Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cellsE E Kelley, E J Modest, C P Burns
Lipids|March 1, 1993
The effect of culture medium composition on ether lipid cytotoxic activityL Diomede, B Piovani, E J Modest, et al.
Lipids|November 1, 1987
Neoplastic cell inhibition with new ether lipid analogsA Noseda, M E Berens, C Piantadosi, et al.
Pageof 5